Seeking Alpha
  • Sinjjn Smythe
    (THLD): shares are initiated with a Buy at Mizuho, which establishes a $15 target price.
    4/2/12
    Reply (4)
    • Sinjjn Smythe: The broker forecasts global sales for TH-302 in pancreatic cancer and STS to reach $1.7 billion by 2018.
      4/2/12
    • Sinjjn Smythe: Guys this is a company that has made no money in 4 years and has only 49 million shares floating! Sweeeeeeeeeet!
      4/2/12
    • Sinjjn Smythe: Do you wonder why every time Cramer is asked about THLD. He just's loudly proclaims with a big smile: BUY, BUY, BUY!!!
      4/2/12
    • Sinjjn Smythe: waiting to see why big plays crashed the stock last two days to get into our little Titan! Actually I'm waiting for Merck to buy them out!
      4/2/12